M E Hoatlin
Overview
Explore the profile of M E Hoatlin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
532
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wilson J, Yamamoto K, Marriott A, Hussain S, Sung P, Hoatlin M, et al.
Oncogene
. 2008 Jan;
27(26):3641-52.
PMID: 18212739
Fanconi anemia (FA) is a human disorder characterized by cancer susceptibility and cellular sensitivity to DNA crosslinks and other damages. Thirteen complementation groups and genes are identified, including BRCA2, which...
2.
Sobeck A, Stone S, Hoatlin M
Mol Cell Biol
. 2007 Apr;
27(12):4283-92.
PMID: 17420278
The Fanconi anemia (FA) pathway proteins are thought to be involved in the repair of irregular DNA structures including those encountered by the moving replication fork. However, the nature of...
3.
Xie Y, de Winter J, Waisfisz Q, Nieuwint A, Scheper R, Arwert F, et al.
Br J Haematol
. 2001 Feb;
111(4):1057-64.
PMID: 11167740
Fanconi anaemia (FA) is an autosomal recessive disease strongly predisposing to bone marrow failure and acute myeloid leukaemia (AML). Four FA genes, corresponding to complementation groups A, C, F and...
4.
de Winter J, van der Weel L, de Groot J, Stone S, Waisfisz Q, Arwert F, et al.
Hum Mol Genet
. 2000 Nov;
9(18):2665-74.
PMID: 11063725
Fanconi anemia (FA) is a chromosomal instability syndrome associated with a strong predisposition to cancer, particularly acute myeloid leukemia and squamous cell carcinoma. At the cellular level, FA is characterized...
5.
Heinrich M, Silvey K, Stone S, Zigler A, Griffith D, Montalto M, et al.
Blood
. 2000 Jun;
95(12):3970-7.
PMID: 10845936
The Fanconi Anemia (FA) Group C complementation group gene (FANCC) encodes a protein, FANCC, with a predicted M(r) of 63,000 daltons. FANCC is found in both the cytoplasmic and the...
6.
van de Vrugt H, Cheng N, de Vries Y, Rooimans M, de Groot J, Scheper R, et al.
Mamm Genome
. 2000 Apr;
11(4):326-31.
PMID: 10754110
Fanconi anemia (FA) is an autosomal recessive disorder in humans characterized by bone marrow failure, cancer predisposition, and cellular hypersensitivity to cross-linking agents such as mitomycin C and diepoxybutane. FA...
7.
de Winter J, Rooimans M, van der Weel L, van Berkel C, Alon N, de Groot J, et al.
Nat Genet
. 1999 Dec;
24(1):15-6.
PMID: 10615118
No abstract available.
8.
Hoatlin M, Zhi Y, Ball H, Silvey K, Melnick A, Stone S, et al.
Blood
. 1999 Nov;
94(11):3737-47.
PMID: 10572087
Fanconi anemia (FA) is an autosomal recessive cancer susceptibility syndrome. The phenotype includes developmental defects, bone marrow failure, and cell cycle abnormalities. At least eight complementation groups (A-H) exist, and...
9.
Waisfisz Q, de Winter J, Kruyt F, de Groot J, van der Weel L, Dijkmans L, et al.
Proc Natl Acad Sci U S A
. 1999 Sep;
96(18):10320-5.
PMID: 10468606
Fanconi anemia (FA) is a recessively inherited disease characterized at the cellular level by spontaneous chromosomal instability and specific hypersensitivity to cross-linking agents. FA is genetically heterogeneous, comprising at least...
10.
Waisfisz Q, Morgan N, Savino M, de Winter J, van Berkel C, Hoatlin M, et al.
Nat Genet
. 1999 Aug;
22(4):379-83.
PMID: 10431244
Somatic mosaicism due to reversion of a pathogenic allele to wild type has been described in several autosomal recessive disorders. The best known mechanism involves intragenic mitotic recombination or gene...